In severe combined immunodeficient (SCID) mice subcutaneously injected with vertebral-cancer of the prostate (VCaP) prostate cancer cell lines, systemic administration of anti-CCL2 neutralizing antibody has significantly slowed tumor growth and significantly suppressed angiogenesis and infiltration of CD68+ macrophages into tumor tissues [107]. Here, CD68 is linked to neoplasm.